Log In
BCIQ
Print this Print this
 

GSK3342830

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionCephalosporin antibiotic
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationGram-negative bacterial infection
Indication DetailsTreat Gram-negative bacterial infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/28/2010

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today